학술논문

Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States.
Document Type
Case Study
Source
Open Forum Infectious Diseases. Aug2022, Vol. 9 Issue 8, p1-4. 4p.
Subject
*MONKEYPOX
*INVESTIGATIONAL drugs
*SMALLPOX
Language
ISSN
2328-8957
Abstract
A large, ongoing multicountry outbreak of human monkeypox has the potential to cause considerable morbidity and mortality. Therapeutics for the treatment of smallpox, a related Orthopoxvirus , may be used and affect the natural history of monkeypox. We present 3 patients from our hospitals treated with tecovirimat, a pan- Orthopoxvirus inhibitor currently available under an expanded access investigational new drug protocol for monkeypox. [ABSTRACT FROM AUTHOR]